SMS Pharmaceuticals Ltd (SMSPHARMA):企業の財務・戦略的SWOT分析

◆英語タイトル:SMS Pharmaceuticals Ltd (SMSPHARMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0964
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

SMS Pharmaceuticals Ltd (SMSPHARMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SMS Pharmaceuticals Ltd (SMS Pharma) is a manufacturer of active pharmaceutical ingredients (APIs) and intermediates that develops offers anti-fungal, anti-ulcer, anti-migraine, anti-hypersensitive, anti-psychotic, anti-viral and other products. Its pipeline products include Ticagrelor, Clopidogrel Bisulfate, Montelukast Sodium, Apixaban, Rivaroxaban, Gabapentin Enacarbil, Lamotrigine and Sofosbuvir among others. Its contract research includes study of synthetic feasibility, process development and scale up, selection of synthetic route and lead optimization and analogue synthesis. Its manufacturing facilities include Khazipally unit, Bachupally unit, Jeedimetla unit and Visakhapatnam unit. SMS Pharma is headquartered in Hyderabad, Telangana, India.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
SMS Pharmaceuticals Ltd – Key Facts
SMS Pharmaceuticals Ltd – Key Employees
SMS Pharmaceuticals Ltd – Key Employee Biographies
SMS Pharmaceuticals Ltd – Major Products and Services
SMS Pharmaceuticals Ltd – History
SMS Pharmaceuticals Ltd – Company Statement
SMS Pharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
SMS Pharmaceuticals Ltd – Business Description
SMS Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
SMS Pharmaceuticals Ltd – Strengths
SMS Pharmaceuticals Ltd – Weaknesses
SMS Pharmaceuticals Ltd – Opportunities
SMS Pharmaceuticals Ltd – Threats
SMS Pharmaceuticals Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
SMS Pharmaceuticals Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
SMS Pharmaceuticals Ltd, Key Facts
SMS Pharmaceuticals Ltd, Key Employees
SMS Pharmaceuticals Ltd, Key Employee Biographies
SMS Pharmaceuticals Ltd, Major Products and Services
SMS Pharmaceuticals Ltd, History
SMS Pharmaceuticals Ltd, Other Locations
SMS Pharmaceuticals Ltd, Key Competitors
SMS Pharmaceuticals Ltd, Ratios based on current share price
SMS Pharmaceuticals Ltd, Annual Ratios
SMS Pharmaceuticals Ltd, Annual Ratios (Cont...1)
SMS Pharmaceuticals Ltd, Annual Ratios (Cont...2)
SMS Pharmaceuticals Ltd, Interim Ratios
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
SMS Pharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
SMS Pharmaceuticals Ltd, Performance Chart (2015 - 2019)
SMS Pharmaceuticals Ltd, Ratio Charts
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
SMS Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[SMS Pharmaceuticals Ltd (SMSPHARMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioClin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioClin Therapeutics Inc (BioClin) is a clinical stage biotechnology company developing protein therapeutics for genetic disorders. Its lead product candidate B-701 is a human monoclonal antibody which targets the activity of FGFR3 (fibroblast growth factor receptor 3) and does not interact …
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • Eagle Pharmaceuticals Inc (EGRX):企業の財務・戦略的SWOT分析
    Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • DKSH Holding Ltd. (DKSH):企業の財務・戦略的SWOT分析
    DKSH Holding Ltd. (DKSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cobra Electronics Corporation:企業の戦略的SWOT分析
    Cobra Electronics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Avesthagen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevent …
  • Baytex Energy Corp (BTE):企業の財務・戦略的SWOT分析
    Baytex Energy Corp (BTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Clearside BioMedical Inc (CLSD):医療機器:M&Aディール及び事業提携情報
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Tanfield Group PLC (TAN):企業の財務・戦略的SWOT分析
    Summary Tanfield Group plc (Tanfield Group) is an investment company that offers electrical investments. The company designs and produces electric commercial vehicles for short haul urban fleets. It also produces zero-emission vehicles that deliver better performance to traditional diesel trucks. Ta …
  • Eutelsat Communications Group:企業の戦略・SWOT・財務分析
    Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report Summary Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sevion Therapeutics Inc (SVON)-製薬・医療分野:企業M&A・提携分析
    Summary Sevion Therapeutics Inc (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has developed protein nanocage system that allows delivery of nucleic …
  • Sunesis Pharmaceuticals Inc (VIRX):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Global Payments Inc.:企業の戦略・SWOT・財務情報
    Global Payments Inc. - Strategy, SWOT and Corporate Finance Report Summary Global Payments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • HubSpot, Inc.:企業のM&A・事業提携・投資動向
    HubSpot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HubSpot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Ocean Power Technologies Inc (OPTT):電力:M&Aディール及び事業提携情報
    Summary Ocean Power Technologies, Inc. (OPT) is a provider of ocean energy solutions. The company harnesses the abundant wave power to draw out renewable energy; and commercializes ocean wave power conversion technology products. The company's PB3 PowerBuoy integrates patented technologies in hydrod …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Berkshire Hathaway Energy Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • Nordea Bank AB:企業の戦略・SWOT・財務情報
    Nordea Bank AB - Strategy, SWOT and Corporate Finance Report Summary Nordea Bank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務情報
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Williams Partners LP:企業のM&A・事業提携・投資動向
    Williams Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Williams Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆